Diastolic dysfunction

Sara Paul1

  • 1Hickory Cardiology Associates, 1771 Tate Blvd. SE, Suite 201, Hickory, NC 28602, USA. smcpaul@earthlink.net

Insights

Diastolic heart failure has a lower mortality rate than systolic heart failure but remains higher than in healthy individuals. Further research is needed to improve diastolic heart failure treatment strategies.

Area of Science:

  • Cardiology
  • Heart Failure Research

Background:

  • Diastolic heart failure, while having better survival rates than systolic heart failure, still presents a significant mortality risk compared to age-matched controls.
  • Five-year mortality rates are approximately 50% for systolic heart failure and 25% for diastolic heart failure.
  • Outcomes in elderly patients (over 65) with systolic and diastolic dysfunction may show greater similarity.

Purpose of the Study:

  • To highlight the current understanding of diastolic heart failure management.
  • To emphasize the need for evidence-based treatment strategies.
  • To underscore the importance of ongoing research in diastolic heart failure.

Main Methods:

  • Review of existing literature and clinical guidelines for heart failure management.
  • Analysis of mortality data for systolic and diastolic heart failure.
  • Examination of current therapeutic approaches based on expert consensus and mechanistic understanding.

Main Results:

  • Diastolic heart failure demonstrates a higher mortality rate than age-matched controls, despite being lower than systolic heart failure.
  • Large-scale clinical trials evaluating specific therapies for diastolic heart failure are lacking.
  • Current management guidelines for diastolic heart failure are largely based on expert opinion and limited evidence.

Conclusions:

  • While diastolic heart failure has a better prognosis than systolic heart failure, its mortality remains elevated.
  • There is a critical need for robust, evidence-based clinical trials to guide the management of diastolic heart failure.
  • Future research endeavors are essential to deepen the understanding and enhance treatment strategies for diastolic heart failure.

Related Concept Videos

Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send blood...
Mitral Regurgitation I: Introduction01:20

Mitral Regurgitation I: Introduction

Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...